CN105012720A - Traditional Chinese medicine composition for treating osteopathy - Google Patents
Traditional Chinese medicine composition for treating osteopathy Download PDFInfo
- Publication number
- CN105012720A CN105012720A CN201510541151.2A CN201510541151A CN105012720A CN 105012720 A CN105012720 A CN 105012720A CN 201510541151 A CN201510541151 A CN 201510541151A CN 105012720 A CN105012720 A CN 105012720A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating osteopathy. The traditional Chinese medicine composition comprises the following substances in parts by weight: 1-3 parts of gastrodiae tuber, 4-8 parts of dragon's blood, 1-2 parts of musk, 3-6 parts of frankincense, 3-6 parts of myrrh, 2-5 parts of liquid storax, 3-5 parts of angelica, 2-6 parts of Szechuan lovage rhizome, 1-5 parts of radix paeoniae rubra, 2-6 parts of astragalus membranaceus, 1-2 parts of radix aucklandiae, 1-2 parts of sandalwood, 2-4 parts of carthamus tinctorius, 2-6 parts of trberculate speranskia herb, 1-3 parts of radix salviae miltiorrhizae, 1-3 parts of spatholobus stem, 2-5 parts of panax notoginseng, 1-2 parts of radix saposhnikoviae, 1-2 parts of stephania tetrandra, 1-3 parts of papaya, 1-3 parts of cortex acanthopanacis, 1-2 parts of seed cowherb, 1-3 parts of radix cyathulae, 1-2 parts of notopterygium root, 1-2 parts of pubescent angelica root, 2-5 parts of cassia twig, 2-5 parts of rhizoma atractylodis macrocephalae, 2-5 parts of paniculate swallowwort root, 3-6 parts of clematis root, 2-6 parts of dipsacus asperoides, 2-4 parts of rhizoma dioscoreae nipponicae and 1-3 parts of Chinese hydrangeavine root-bark. The traditional Chinese medicine composition adopts natural Chinese herbal raw materials, and has the advantages of being wide in Chinese herb source, low in cost, simple to prepare, little in toxic or side effect, and remarkable in treating effect.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of osteopathia.
Background technology
Rheumatoid arthritis, also known as rheumatoid, is the chronic systemic inflammation disease that a kind of cause of disease not yet understands, for main clinical manifestation, belongs to autoimmune inflammatory disease with pathological changes outside chronic, symmetry, many synovial jointss inflammation and joint.This disease is apt to occur in the Minor articulus such as hands, wrist, foot, and recurrent exerbation, is symmetric.
Rheumatoid arthritis is the prerequisite of all rehabilitations, and for rheumatoid patient, application has the Chinese medicine of spleen invigorating, removing dampness, dredging collateral effect, to improve arthralgia, swelling, the symptom such as stiff.Meanwhile, can damp be dispelled, benefiting QI and nourishing blood, obviously strengthen patient's reticuloendothelial system phagocytic function, promote lymphocyte transformation and form active garland.Pain relieving Western medicine: can only pain relieving, can not control pain, long-term taking easily produces dependency and toxic and side effects, not only unhelpful but also stimulating intestine and stomach, damage Liver and kidney.Naturopathy: naturopathy comprises the methods such as electrotherapy, infrared ray radiation, thermotherapy, and all patients doing physical therapy know, can be more comfortable when doing physical therapy, again can be as before after not doing.Massage acupuncture: substantially identical with naturopathy object.Be exactly the clinical symptoms to alleviate patient, but not radical cure means.Operative treatment: because indication requires very strict, the features such as the crowd being applicable to clinically performing an operation, less than 5%, adds costly, and wound is large, and convalescent period is long, easy recurrence, so cannot popularize in an all-round way at all.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of osteopathia.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of osteopathia, it comprises the material of following weight portion: Rhizoma Gastrodiae 1-3 part, Sanguis Draxonis 4-8 part, Moschus 1-2 part, Olibanum 3-6 part, Myrrha 3-6 part, Styrax 2-5 part, Radix Angelicae Sinensis 3-5 part, Rhizoma Chuanxiong 2-6 part, Radix Paeoniae Rubra 1-5 part, Radix Astragali 2-6 part, Radix Aucklandiae 1-2 part, Lignum Santali Albi 1-2 part, Flos Carthami 2-4 part, Tuberculate Speranskia Herb 2-6 part, Radix Salviae Miltiorrhizae 1-3 part, Caulis Spatholobi 1-3 part, Radix Notoginseng 2-5 part, Radix Saposhnikoviae 1-2 part, Radix Stephaniae Tetrandrae 1-2 part, Fructus Chaenomelis 1-3 part, Cortex Acanthopancis 1-3 part, Semen Vaccariae 1-2 part, Radix Cyathulae 1-3 part, Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Ramulus Cinnamomi 2-5 part, Rhizoma Atractylodis Macrocephalae 2-5 part, Radix Cynanchi Paniculati 2-5 part, Radix Clematidis 3-6 part, Radix Dipsaci 2-6 part, Rhizoma Dioscoreae Nipponicae 2-4 part and Cortex schizophragmatis integrifolii radicis 1-3 part.
Preferably, the Chinese medicine composition for the treatment of osteopathia of the present invention comprises the material of following weight portion: 2 parts, Rhizoma Gastrodiae, Sanguis Draxonis 5 parts, 1 part, Moschus, Olibanum 5 parts, Myrrha 5 parts, Styrax 3 parts, Radix Angelicae Sinensis 3 parts, Rhizoma Chuanxiong 5 parts, Radix Paeoniae Rubra 3 parts, the Radix Astragali 5 parts, the Radix Aucklandiae 1 part, 1 part, Lignum Santali Albi, 3 parts, Flos Carthami, Tuberculate Speranskia Herb 5 parts, Radix Salviae Miltiorrhizae 2 parts, Caulis Spatholobi 2 parts, Radix Notoginseng 3 parts, Radix Saposhnikoviae 1 part, Radix Stephaniae Tetrandrae 1 part, Fructus Chaenomelis 1 part, Cortex Acanthopancis 1 part, Semen Vaccariae 1 part, Radix Cyathulae 1 part, Rhizoma Et Radix Notopterygii 1 part, Radix Angelicae Pubescentis 1 part, Ramulus Cinnamomi 3 parts, the Rhizoma Atractylodis Macrocephalae 3 parts, Radix Cynanchi Paniculati 3 parts, Radix Clematidis 5 parts, Radix Dipsaci 3 parts, Rhizoma Dioscoreae Nipponicae 3 parts and Cortex schizophragmatis integrifolii radicis 2 parts.
More preferably, the Chinese medicine composition for the treatment of osteopathia of the present invention also comprises the material of following weight portion: Fructus Dracontomeli Duperreani 3 parts, 2 parts, ferrum railing, Calendula officinalis 1 part, Herba Chrysosplenii Macrophylli 2 parts, Fructus Perillae 2 parts, Radix seu Caulis Schisandrae Sinensis 1 part, Herba Erigerontis Annui 2 parts, Equisetum sylvaticum L. 1 part, thin,tough silk hair chrysanthemum 1 part, Caulis Marsdeniae Tenacissimae 2 parts and Herba Solani Nigri 2 parts.
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum, decoction or implant.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment osteopathia, described compositions comprises the material of following weight portion: Rhizoma Gastrodiae 1-3 part, Sanguis Draxonis 4-8 part, Moschus 1-2 part, Olibanum 3-6 part, Myrrha 3-6 part, Styrax 2-5 part, Radix Angelicae Sinensis 3-5 part, Rhizoma Chuanxiong 2-6 part, Radix Paeoniae Rubra 1-5 part, Radix Astragali 2-6 part, Radix Aucklandiae 1-2 part, Lignum Santali Albi 1-2 part, Flos Carthami 2-4 part, Tuberculate Speranskia Herb 2-6 part, Radix Salviae Miltiorrhizae 1-3 part, Caulis Spatholobi 1-3 part, Radix Notoginseng 2-5 part, Radix Saposhnikoviae 1-2 part, Radix Stephaniae Tetrandrae 1-2 part, Fructus Chaenomelis 1-3 part, Cortex Acanthopancis 1-3 part, Semen Vaccariae 1-2 part, Radix Cyathulae 1-3 part, Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Ramulus Cinnamomi 2-5 part, Rhizoma Atractylodis Macrocephalae 2-5 part, Radix Cynanchi Paniculati 2-5 part, Radix Clematidis 3-6 part, Radix Dipsaci 2-6 part, Rhizoma Dioscoreae Nipponicae 2-4 part and Cortex schizophragmatis integrifolii radicis 1-3 part.
Preferably, described compositions comprises the material of following weight portion: 2 parts, Rhizoma Gastrodiae, Sanguis Draxonis 5 parts, 1 part, Moschus, Olibanum 5 parts, Myrrha 5 parts, Styrax 3 parts, Radix Angelicae Sinensis 3 parts, Rhizoma Chuanxiong 5 parts, Radix Paeoniae Rubra 3 parts, the Radix Astragali 5 parts, the Radix Aucklandiae 1 part, 1 part, Lignum Santali Albi, 3 parts, Flos Carthami, Tuberculate Speranskia Herb 5 parts, Radix Salviae Miltiorrhizae 2 parts, Caulis Spatholobi 2 parts, Radix Notoginseng 3 parts, Radix Saposhnikoviae 1 part, Radix Stephaniae Tetrandrae 1 part, Fructus Chaenomelis 1 part, Cortex Acanthopancis 1 part, Semen Vaccariae 1 part, Radix Cyathulae 1 part, Rhizoma Et Radix Notopterygii 1 part, Radix Angelicae Pubescentis 1 part, Ramulus Cinnamomi 3 parts, the Rhizoma Atractylodis Macrocephalae 3 parts, Radix Cynanchi Paniculati 3 parts, Radix Clematidis 5 parts, Radix Dipsaci 3 parts, Rhizoma Dioscoreae Nipponicae 3 parts and Cortex schizophragmatis integrifolii radicis 2 parts.
More preferably, described compositions also comprises the material of following weight portion: Fructus Dracontomeli Duperreani 3 parts, 2 parts, ferrum railing, Calendula officinalis 1 part, Herba Chrysosplenii Macrophylli 2 parts, Fructus Perillae 2 parts, Radix seu Caulis Schisandrae Sinensis 1 part, Herba Erigerontis Annui 2 parts, Equisetum sylvaticum L. 1 part, thin,tough silk hair chrysanthemum 1 part, Caulis Marsdeniae Tenacissimae 2 parts and Herba Solani Nigri 2 parts.
Most preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum, decoction or implant.
In the present invention, Tuberculate Speranskia Herb Classification system is Herba SperanskiaeTuberculatae.
Pharmaceutical composition of the present invention can also use as implant.
1, prescription processing: whole gastrodia tuber Tuberculate Speranskia Herb Sanguis Draxonis Radix Notoginseng is processed into powder, loads in bottle after high temperature sterilize process
2, Sanguis Draxonis 4-8 gram is soaked, Moschus 1-2 gram, Olibanum 3-6 gram, Myrrha 3-6 gram, Styrax 2-5 gram, grinds to the powder and puts into 95% ethanol 120-180ml, uncaps after container being built closed 3 months in five minutes and solution A is made in the speed filtration that above-mentioned solution drips with 20-30 per minute.
3, B liquid, Radix Angelicae Sinensis 3-5 gram, Rhizoma Chuanxiong 2-6 gram, Radix Paeoniae Rubra 3 grams, Radix Astragali 2-6 gram, Radix Aucklandiae 1-2 gram, Lignum Santali Albi 1-2 gram, Flos Carthami 2-4 gram, Tuberculate Speranskia Herb 2-6 gram, Radix Salviae Miltiorrhizae 1-3 gram, Caulis Spatholobi 1-3 gram, Radix Notoginseng 2-5 gram, Radix Saposhnikoviae 1-2 gram, Radix Stephaniae Tetrandrae 1-2 gram, whole gastrodia tuber 1-3 gram, Fructus Chaenomelis 1-3 gram, Cortex Acanthopancis 1-3 gram, Semen Vaccariae 1-2 gram, Radix Cyathulae 1-3 gram, Rhizoma Et Radix Notopterygii 1-2 gram, Radix Angelicae Pubescentis 1-2 gram, Ramulus Cinnamomi 2-5 gram, Rhizoma Atractylodis Macrocephalae 2-5 gram, Radix Cynanchi Paniculati 2-5 gram of Radix Clematidis 3-6 gram, Radix Dipsaci 2-6 gram, Rhizoma Dioscoreae Nipponicae 2-4 gram, Cortex schizophragmatis integrifolii radicis 1-3 gram, by the process of said medicine coarser powder high temperature sterilize, add in 95% ethanol 600-900ml, by seal of vessel after uncapping five minutes, within every 72 hours, rock once, after 3 months, above-mentioned solution is filtered with the speed that 20-30 per minute drips and make B solution
4, the solution A cured and B solution mixing are shaken up and make biological tincture, load in the intact glass container of sterilizing
5, leaching is washed different in nature bioprotein material 1-3cm long, loads in the intact container of sterilizing, and wash three hours, three times repeatedly with 75% medical alcohol leaching, dry in rear special business medicinal tincture and soak 3 months, make medicine rod, its shape is as pin.
6, the used time is pulled out and puts into 75% medical alcohol and soak 30 minutes i.e. human implantables.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 unguentum of the present invention
Take 200 grams, Rhizoma Gastrodiae, Sanguis Draxonis 500 grams, 100 grams, Moschus, Olibanum 500 grams, Myrrha 500 grams, Styrax 300 grams, Radix Angelicae Sinensis 300 grams, Rhizoma Chuanxiong 500 grams, Radix Paeoniae Rubra 300 grams, the Radix Astragali 500 grams, the Radix Aucklandiae 100 grams, 100 grams, Lignum Santali Albi, 300 grams, Flos Carthami, Tuberculate Speranskia Herb 500 grams, Radix Salviae Miltiorrhizae 200 grams, Caulis Spatholobi 200 grams, Radix Notoginseng 300 grams, Radix Saposhnikoviae 100 grams, Radix Stephaniae Tetrandrae 100 grams, Fructus Chaenomelis 100 grams, Cortex Acanthopancis 100 grams, Semen Vaccariae 100 grams, Radix Cyathulae 100 grams, Rhizoma Et Radix Notopterygii 100 grams, Radix Angelicae Pubescentis 100 grams, Ramulus Cinnamomi 300 grams, the Rhizoma Atractylodis Macrocephalae 300 grams, Radix Cynanchi Paniculati 300 grams, Radix Clematidis 500 grams, Radix Dipsaci 300 grams, Rhizoma Dioscoreae Nipponicae 300 grams and Cortex schizophragmatis integrifolii radicis 200 grams, pulverize, cross 60 mesh sieves, add 1200 grams, vaseline and lanoline 1200 grams, stir, obtain.
Embodiment 2 unguentum of the present invention
Take 200 grams, Rhizoma Gastrodiae, Sanguis Draxonis 500 grams, 100 grams, Moschus, Olibanum 500 grams, Myrrha 500 grams, Styrax 300 grams, Radix Angelicae Sinensis 300 grams, Rhizoma Chuanxiong 500 grams, Radix Paeoniae Rubra 300 grams, the Radix Astragali 500 grams, the Radix Aucklandiae 100 grams, 100 grams, Lignum Santali Albi, 300 grams, Flos Carthami, Tuberculate Speranskia Herb 500 grams, Radix Salviae Miltiorrhizae 200 grams, Caulis Spatholobi 200 grams, Radix Notoginseng 300 grams, Radix Saposhnikoviae 100 grams, Radix Stephaniae Tetrandrae 100 grams, Fructus Chaenomelis 100 grams, Cortex Acanthopancis 100 grams, Semen Vaccariae 100 grams, Radix Cyathulae 100 grams, Rhizoma Et Radix Notopterygii 100 grams, Radix Angelicae Pubescentis 100 grams, Ramulus Cinnamomi 300 grams, the Rhizoma Atractylodis Macrocephalae 300 grams, Radix Cynanchi Paniculati 300 grams, Radix Clematidis 500 grams, Radix Dipsaci 300 grams, Rhizoma Dioscoreae Nipponicae 300 grams, Cortex schizophragmatis integrifolii radicis 200 grams, Fructus Dracontomeli Duperreani 300 grams, 200 grams, ferrum railing, Calendula officinalis 100 grams, Herba Chrysosplenii Macrophylli 200 grams, Fructus Perillae 200 grams, Radix seu Caulis Schisandrae Sinensis 100 grams, Herba Erigerontis Annui 200 grams, Equisetum sylvaticum L. 100 grams, thin,tough silk hair chrysanthemum 100 grams, Caulis Marsdeniae Tenacissimae 200 grams and Herba Solani Nigri 200 grams, pulverize, cross 60 mesh sieves, add 1200 grams, vaseline and lanoline 1200 grams, stir, obtain.
Experimental example
Diagnostic criteria
Western medicine diagnose was both diagnosed according to American Rheumatism Association's revision diagnosis of rheumatoid arthritis standard in 1987.Diagnostic criteria comprises: (1) deadlock in morning is 1h (course of disease >=6 week) at least; (2) 3 or more than 3 arthralgias; (3) wrist, metacarpophalangeal joints or near-end refer to ask swollen joint; (4) symmetry swollen joint; (5) subcutaneous nodule; (6) hands X-ray film changes; (7) rheumatoid factor positive (titre > 1: 32).All possess above 4 standards, and patient with connection portion symptom for main person examines as rheumatoid arthritis.
Tcm diagnosis is ridiculed according to the diagnosis basis of arthromyodynia in disease of tcm Standardization of diagnosis and curative effect and is diagnosed.Patients is joint swelling and pain, localized pain, and morning, stiff joint stuffiness, met then pain play of trembling with fear, and local fear of cold is afraid of cold, thin white fur of tongue, and floating and tense pulse or heavy tight person are diagnosed as wind-cold-damp retention type arthromyodynia.Possess above condition, and patient with knee symptom for main person examines as rheumatoid gonarthritis.
Inclusive criteria
Meet Western medicine diagnose standard and tcm diagnosis standard simultaneously.
Exclusion standard:
1. advanced joint generation severe deformities, joints lose merit able one;
2. basic body constitution is poor, is associated with the obvious abnormal person of cardiovascular system diseases, disease of hematopoietic system or hepatic and renal function;
3. gestation and women breast-feeding their children;
4. the patient of peptic ulcer patients of active is in;
5. the person that suffers from mental sickness;
6. the age is less than 18 years old or is greater than 65 years old.
Selector close standard of stating patient 100 example, wherein man 50 example, female 50 example, patient age 25-55 year, the mean age be (40 ± 3) year, be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 50 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the unguentum of preparation in embodiment 1 to treat, every day three times, each arthritis sore spot using 15 grams of unguentum to be coated in patient equably, continuously treatment 7 weeks.
Treatment group 2 uses the unguentum of preparation in embodiment 2 to treat, every day three times, each arthritis sore spot using 15 grams of unguentum to be coated in patient equably, continuously treatment 7 weeks.
Criterion of therapeutical effect
Curative effect determinate standard with reference to rheumatism Professional Committee of CAIM (Chinese Association Of Integrative Medicine) revision in 1988 is according to specifying.Cure; Arthralgia disappears, and function is improved or recovered normal, and main test index recovers normal; Effective; Arthralgia is clearly better or disappears, and function is improved, main test index recovery or close normal; Effective: arthralgia takes a turn for the better, main test index trend is normal; Invalid: clinical symptoms and sign are without improvement, and main test index is without improvement.
Statistical method
Utilize SPSS 13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts x
2inspection, P < 0.05 represents that difference has statistical significance.
Therapeutic outcome
For treatment group 1, cure 18 examples, effective 12 examples, effective 13 examples, invalid 7 examples, total effective rate is 86%; For treatment group 2, cure 20 examples, effective 15 examples, effective 12 examples, invalid 3 examples, total effective rate is 94%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).The effect for the treatment of group 2 is better than the effect for the treatment of group 1.
Carry out the monitoring of blood, urine, stool routine examination and hepatic and renal function to two groups of patients before and after treatment, in time monitoring untoward reaction occurs, and it compares and sees the following form:
Claims (8)
1. treat the Chinese medicine composition of osteopathia for one kind, it is characterized in that, it comprises the material of following weight portion: Rhizoma Gastrodiae 1-3 part, Sanguis Draxonis 4-8 part, Moschus 1-2 part, Olibanum 3-6 part, Myrrha 3-6 part, Styrax 2-5 part, Radix Angelicae Sinensis 3-5 part, Rhizoma Chuanxiong 2-6 part, Radix Paeoniae Rubra 1-5 part, Radix Astragali 2-6 part, Radix Aucklandiae 1-2 part, Lignum Santali Albi 1-2 part, Flos Carthami 2-4 part, Tuberculate Speranskia Herb 2-6 part, Radix Salviae Miltiorrhizae 1-3 part, Caulis Spatholobi 1-3 part, Radix Notoginseng 2-5 part, Radix Saposhnikoviae 1-2 part, Radix Stephaniae Tetrandrae 1-2 part, Fructus Chaenomelis 1-3 part, Cortex Acanthopancis 1-3 part, Semen Vaccariae 1-2 part, Radix Cyathulae 1-3 part, Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Ramulus Cinnamomi 2-5 part, Rhizoma Atractylodis Macrocephalae 2-5 part, Radix Cynanchi Paniculati 2-5 part, Radix Clematidis 3-6 part, Radix Dipsaci 2-6 part, Rhizoma Dioscoreae Nipponicae 2-4 part and Cortex schizophragmatis integrifolii radicis 1-3 part.
2. the Chinese medicine composition for the treatment of osteopathia according to claim 1, it is characterized in that, it comprises the material of following weight portion: 2 parts, Rhizoma Gastrodiae, Sanguis Draxonis 5 parts, 1 part, Moschus, Olibanum 5 parts, Myrrha 5 parts, Styrax 3 parts, Radix Angelicae Sinensis 3 parts, Rhizoma Chuanxiong 5 parts, Radix Paeoniae Rubra 3 parts, the Radix Astragali 5 parts, the Radix Aucklandiae 1 part, 1 part, Lignum Santali Albi, 3 parts, Flos Carthami, Tuberculate Speranskia Herb 5 parts, Radix Salviae Miltiorrhizae 2 parts, Caulis Spatholobi 2 parts, Radix Notoginseng 3 parts, Radix Saposhnikoviae 1 part, Radix Stephaniae Tetrandrae 1 part, Fructus Chaenomelis 1 part, Cortex Acanthopancis 1 part, Semen Vaccariae 1 part, Radix Cyathulae 1 part, Rhizoma Et Radix Notopterygii 1 part, Radix Angelicae Pubescentis 1 part, Ramulus Cinnamomi 3 parts, the Rhizoma Atractylodis Macrocephalae 3 parts, Radix Cynanchi Paniculati 3 parts, Radix Clematidis 5 parts, Radix Dipsaci 3 parts, Rhizoma Dioscoreae Nipponicae 3 parts and Cortex schizophragmatis integrifolii radicis 2 parts.
3. the Chinese medicine composition for the treatment of osteopathia according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Fructus Dracontomeli Duperreani 3 parts, 2 parts, ferrum railing, Calendula officinalis 1 part, Herba Chrysosplenii Macrophylli 2 parts, Fructus Perillae 2 parts, Radix seu Caulis Schisandrae Sinensis 1 part, Herba Erigerontis Annui 2 parts, Equisetum sylvaticum L. 1 part, thin,tough silk hair chrysanthemum 1 part, Caulis Marsdeniae Tenacissimae 2 parts and Herba Solani Nigri 2 parts.
4. the Chinese medicine composition for the treatment of osteopathia according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum, decoction or implant.
5. the purposes of compositions in the Chinese medicine of preparation treatment osteopathia, it is characterized in that, described compositions comprises the material of following weight portion: Rhizoma Gastrodiae 1-3 part, Sanguis Draxonis 4-8 part, Moschus 1-2 part, Olibanum 3-6 part, Myrrha 3-6 part, Styrax 2-5 part, Radix Angelicae Sinensis 3-5 part, Rhizoma Chuanxiong 2-6 part, Radix Paeoniae Rubra 1-5 part, Radix Astragali 2-6 part, Radix Aucklandiae 1-2 part, Lignum Santali Albi 1-2 part, Flos Carthami 2-4 part, Tuberculate Speranskia Herb 2-6 part, Radix Salviae Miltiorrhizae 1-3 part, Caulis Spatholobi 1-3 part, Radix Notoginseng 2-5 part, Radix Saposhnikoviae 1-2 part, Radix Stephaniae Tetrandrae 1-2 part, Fructus Chaenomelis 1-3 part, Cortex Acanthopancis 1-3 part, Semen Vaccariae 1-2 part, Radix Cyathulae 1-3 part, Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Ramulus Cinnamomi 2-5 part, Rhizoma Atractylodis Macrocephalae 2-5 part, Radix Cynanchi Paniculati 2-5 part, Radix Clematidis 3-6 part, Radix Dipsaci 2-6 part, Rhizoma Dioscoreae Nipponicae 2-4 part and Cortex schizophragmatis integrifolii radicis 1-3 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: 2 parts, Rhizoma Gastrodiae, Sanguis Draxonis 5 parts, 1 part, Moschus, Olibanum 5 parts, Myrrha 5 parts, Styrax 3 parts, Radix Angelicae Sinensis 3 parts, Rhizoma Chuanxiong 5 parts, Radix Paeoniae Rubra 3 parts, the Radix Astragali 5 parts, the Radix Aucklandiae 1 part, 1 part, Lignum Santali Albi, 3 parts, Flos Carthami, Tuberculate Speranskia Herb 5 parts, Radix Salviae Miltiorrhizae 2 parts, Caulis Spatholobi 2 parts, Radix Notoginseng 3 parts, Radix Saposhnikoviae 1 part, Radix Stephaniae Tetrandrae 1 part, Fructus Chaenomelis 1 part, Cortex Acanthopancis 1 part, Semen Vaccariae 1 part, Radix Cyathulae 1 part, Rhizoma Et Radix Notopterygii 1 part, Radix Angelicae Pubescentis 1 part, Ramulus Cinnamomi 3 parts, the Rhizoma Atractylodis Macrocephalae 3 parts, Radix Cynanchi Paniculati 3 parts, Radix Clematidis 5 parts, Radix Dipsaci 3 parts, Rhizoma Dioscoreae Nipponicae 3 parts and Cortex schizophragmatis integrifolii radicis 2 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Fructus Dracontomeli Duperreani 3 parts, 2 parts, ferrum railing, Calendula officinalis 1 part, Herba Chrysosplenii Macrophylli 2 parts, Fructus Perillae 2 parts, Radix seu Caulis Schisandrae Sinensis 1 part, Herba Erigerontis Annui 2 parts, Equisetum sylvaticum L. 1 part, thin,tough silk hair chrysanthemum 1 part, Caulis Marsdeniae Tenacissimae 2 parts and Herba Solani Nigri 2 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum, decoction or implant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510541151.2A CN105012720A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating osteopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510541151.2A CN105012720A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating osteopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105012720A true CN105012720A (en) | 2015-11-04 |
Family
ID=54403260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510541151.2A Pending CN105012720A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating osteopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105012720A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770556A (en) * | 2016-04-14 | 2016-07-20 | 山东省立医院 | Traditional Chinese medicine composition for total knee prosthesis postoperative pain easing and nerve soothing |
| CN106344763A (en) * | 2016-10-17 | 2017-01-25 | 周桂岩 | Composition for treating bone diseases and preparation method thereof |
| CN106492342A (en) * | 2016-11-24 | 2017-03-15 | 苏州枫灵医药科技有限公司 | A kind of medical apparatus and instruments for treating lumbago |
| CN109350657A (en) * | 2018-12-10 | 2019-02-19 | 林争鸣 | A kind of composition that treating rheumatism, preparation method and applications |
| CN110368460A (en) * | 2019-08-09 | 2019-10-25 | 甘肃省中医院 | A kind of Chinese medicine composition and preparation method thereof with the promoting flow of qi and blood circulation |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138997A (en) * | 1995-12-21 | 1997-01-01 | 王玉鸿 | Analgesic and its prepn |
| KR20060018536A (en) * | 2004-08-24 | 2006-03-02 | 인성제약(주) | Natural herb extracts having rheumatoid-neuroprotection activity and therapeutic composition |
| CN103920126A (en) * | 2014-04-30 | 2014-07-16 | 翟峰 | Patch for rheumatoid knee arthritis and preparation method thereof |
| CN104435335A (en) * | 2014-12-18 | 2015-03-25 | 王富 | Traditional Chinese medicine for treating cervical spondylosis, lumbar disc diseases, hyperplastic disease of breast and rheumatism and preparation method of traditional Chinese medicine |
-
2015
- 2015-08-28 CN CN201510541151.2A patent/CN105012720A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138997A (en) * | 1995-12-21 | 1997-01-01 | 王玉鸿 | Analgesic and its prepn |
| KR20060018536A (en) * | 2004-08-24 | 2006-03-02 | 인성제약(주) | Natural herb extracts having rheumatoid-neuroprotection activity and therapeutic composition |
| CN103920126A (en) * | 2014-04-30 | 2014-07-16 | 翟峰 | Patch for rheumatoid knee arthritis and preparation method thereof |
| CN104435335A (en) * | 2014-12-18 | 2015-03-25 | 王富 | Traditional Chinese medicine for treating cervical spondylosis, lumbar disc diseases, hyperplastic disease of breast and rheumatism and preparation method of traditional Chinese medicine |
Non-Patent Citations (1)
| Title |
|---|
| 曹国文: "验方治疗慢性风湿关节痛", 《广西中医药》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770556A (en) * | 2016-04-14 | 2016-07-20 | 山东省立医院 | Traditional Chinese medicine composition for total knee prosthesis postoperative pain easing and nerve soothing |
| CN106344763A (en) * | 2016-10-17 | 2017-01-25 | 周桂岩 | Composition for treating bone diseases and preparation method thereof |
| CN106492342A (en) * | 2016-11-24 | 2017-03-15 | 苏州枫灵医药科技有限公司 | A kind of medical apparatus and instruments for treating lumbago |
| CN109350657A (en) * | 2018-12-10 | 2019-02-19 | 林争鸣 | A kind of composition that treating rheumatism, preparation method and applications |
| CN110368460A (en) * | 2019-08-09 | 2019-10-25 | 甘肃省中医院 | A kind of Chinese medicine composition and preparation method thereof with the promoting flow of qi and blood circulation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105012720A (en) | Traditional Chinese medicine composition for treating osteopathy | |
| CN103705866A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN105106852A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and breast cancer | |
| CN103316320A (en) | Traditional Chinese medicinal composition for treating bone diseases | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN104984297A (en) | Application of pharmaceutical composition in preparation of drugs for treating amenorrhea | |
| CN101474361B (en) | Chinese medicine for treating cerebropathy | |
| CN102935133B (en) | Traditional Chinese medicine composition for treating rheumatic arthritis as well as preparation method and application thereof | |
| CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
| CN101239159B (en) | Chinese medicinal composition for treating rheumatoild disease and preparation thereof | |
| CN1172672A (en) | Chinese medicinal herb composition for treating cancer | |
| CN103301326A (en) | Medicament for treating rheumatism, rheumatoid and pain or rheumatism in lower extremities and waist | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN102657736A (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN102451378A (en) | Uterus health capsule for treating gynopathy | |
| CN102813746B (en) | Traditional Chinese medicine composition for treating numbness of fingers | |
| CN112717084A (en) | Traditional Chinese medicine composition for treating hyperprolactinemia, preparation method and application | |
| CN105288538A (en) | Application of medicine composition for preparing medicine for treating amenorrhea | |
| CN105343675A (en) | Traditional Chinese medicine preparation for treating adiposis and preparation method thereof | |
| CN1075727C (en) | Shentong capsule and preparing method thereof | |
| CN103751418A (en) | Traditional Chinese medicine composition for treating restless leg syndrome | |
| CN104013734A (en) | Traditional Chinese medicine oral liquid for treating osteoarthritis | |
| CN103690925A (en) | Traditional Chinese medicinal composition for treating amenorrhea | |
| CN103721188B (en) | A kind of injection care drug preventing cerebrovascular sclerosis and preparation method thereof | |
| CN102743510A (en) | Chinese medicine preparation for treating acute appendicitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151104 |
|
| RJ01 | Rejection of invention patent application after publication |